Cargando…
S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428228/ http://dx.doi.org/10.1097/01.HS9.0000967816.41118.bf |
_version_ | 1785090416663592960 |
---|---|
author | Marouf, Amira Chaubard, Sammara Michot, Jean Marie Rossignol, Julien Golfier, Camille Allangba, Olivier Philippe, Laure Tessoulin, Benoit Chauchet, Adrien Deau, Bénédicte Oberic, Lucie Vargaftig, Jacques Moignet, Aline Clavert, Aline Duléry, Rémy Brisou, Gabriel Tardy, Stéphanie Fataccioli, Virginie Houot, Roch Olivier Casasnovas, Rene Thieblemont, Catherine Ghesquieres, Herve Carras, Sylvain Le Gouill, Steven Cartron, Guillaume Marabelle, Aurélien Tournilhac, Olivier Laurent Damaj, Gandhi Gaulard, Philippe Leval, Laurence De Lemonnier, Francois Bachy, Emmanuel Hermine, Olivier Couronné, Lucile Jaccard, Arnaud |
author_facet | Marouf, Amira Chaubard, Sammara Michot, Jean Marie Rossignol, Julien Golfier, Camille Allangba, Olivier Philippe, Laure Tessoulin, Benoit Chauchet, Adrien Deau, Bénédicte Oberic, Lucie Vargaftig, Jacques Moignet, Aline Clavert, Aline Duléry, Rémy Brisou, Gabriel Tardy, Stéphanie Fataccioli, Virginie Houot, Roch Olivier Casasnovas, Rene Thieblemont, Catherine Ghesquieres, Herve Carras, Sylvain Le Gouill, Steven Cartron, Guillaume Marabelle, Aurélien Tournilhac, Olivier Laurent Damaj, Gandhi Gaulard, Philippe Leval, Laurence De Lemonnier, Francois Bachy, Emmanuel Hermine, Olivier Couronné, Lucile Jaccard, Arnaud |
author_sort | Marouf, Amira |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104282282023-08-17 S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA Marouf, Amira Chaubard, Sammara Michot, Jean Marie Rossignol, Julien Golfier, Camille Allangba, Olivier Philippe, Laure Tessoulin, Benoit Chauchet, Adrien Deau, Bénédicte Oberic, Lucie Vargaftig, Jacques Moignet, Aline Clavert, Aline Duléry, Rémy Brisou, Gabriel Tardy, Stéphanie Fataccioli, Virginie Houot, Roch Olivier Casasnovas, Rene Thieblemont, Catherine Ghesquieres, Herve Carras, Sylvain Le Gouill, Steven Cartron, Guillaume Marabelle, Aurélien Tournilhac, Olivier Laurent Damaj, Gandhi Gaulard, Philippe Leval, Laurence De Lemonnier, Francois Bachy, Emmanuel Hermine, Olivier Couronné, Lucile Jaccard, Arnaud Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428228/ http://dx.doi.org/10.1097/01.HS9.0000967816.41118.bf Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Oral Sessions Marouf, Amira Chaubard, Sammara Michot, Jean Marie Rossignol, Julien Golfier, Camille Allangba, Olivier Philippe, Laure Tessoulin, Benoit Chauchet, Adrien Deau, Bénédicte Oberic, Lucie Vargaftig, Jacques Moignet, Aline Clavert, Aline Duléry, Rémy Brisou, Gabriel Tardy, Stéphanie Fataccioli, Virginie Houot, Roch Olivier Casasnovas, Rene Thieblemont, Catherine Ghesquieres, Herve Carras, Sylvain Le Gouill, Steven Cartron, Guillaume Marabelle, Aurélien Tournilhac, Olivier Laurent Damaj, Gandhi Gaulard, Philippe Leval, Laurence De Lemonnier, Francois Bachy, Emmanuel Hermine, Olivier Couronné, Lucile Jaccard, Arnaud S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title | S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title_full | S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title_fullStr | S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title_full_unstemmed | S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title_short | S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA |
title_sort | s226: efficacy of anti-pd1 therapy in relapsed or refractory extranodal nk/t cell lymphoma: a matched cohort analysis from the lysa |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428228/ http://dx.doi.org/10.1097/01.HS9.0000967816.41118.bf |
work_keys_str_mv | AT maroufamira s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT chaubardsammara s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT michotjeanmarie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT rossignoljulien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT golfiercamille s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT allangbaolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT philippelaure s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT tessoulinbenoit s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT chauchetadrien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT deaubenedicte s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT obericlucie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT vargaftigjacques s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT moignetaline s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT clavertaline s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT duleryremy s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT brisougabriel s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT tardystephanie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT fatacciolivirginie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT houotroch s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT oliviercasasnovasrene s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT thieblemontcatherine s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT ghesquieresherve s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT carrassylvain s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT legouillsteven s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT cartronguillaume s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT marabelleaurelien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT tournilhacolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT laurentdamajgandhi s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT gaulardphilippe s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT levallaurencede s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT lemonnierfrancois s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT bachyemmanuel s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT hermineolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT couronnelucile s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa AT jaccardarnaud s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa |